• DNA alterations in papillary renal cancer. 

  Jackson-Spence, F; Ackerman, C; Szabados, B; Toms, C; Jovaisaite, A; Gunnell, R; Suárez, C; Larkin, J; Patel, P; Valderrama, BP (2023-02-20)

• P126 Trial In Progress: DISCUS: A randomized phase II study comparing 3 vs. 6 cycles of platinum-based chemotherapy prior to maintenance avelumab in advanced urothelial cancer 

  Jackson-Spence, FE; Powles, T; Loriot, Y; Toms, C; Jovaisaite, A; Choy, J; Szabados, BE; Nudds, H; Ackerman, C; Mousa, K (2022-11-01)

• A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot 

  Torr, B; Jones, C; Choi, S; Allen, S; Kavanaugh, G; Hamill, M; Garrett, A; MacMahon, S; Loong, L; Reay, A (2022-12)

• Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomes 

  Burnell, M; Gaba, F; Sobocan, M; Desai, R; Sanderson, S; Loggenberg, K; Gessler, S; Side, L; Brady, AF; Dorkins, H (2022-11)

• Androgen Receptor Expression Is a Predictor of Poor Outcome in Urothelial Carcinoma 

  Szabados, B; Duncan, S; Choy, J; Jackson-Spence, F; Toms, C; Trevisan, G; Berney, DM; Powles, T; Ackerman, C (2022-05-06)

• The role of angiogenic signatures in advanced urothelial carcinoma (aUC) treated with VEGF-targeted therapy 

  Jackson-Spence, FE; Ackerman, C; Khan, M; Grant, M; Soosaipillai, G; Nally, E; Choy, J; Powles, TB; Szabados, BE (2021-06)

• 208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC 

  Schmid, P; Gomez-Pardo, P; Wheatley, D; Roy, P; Krabisch, P; Thill, M; Ledwidge, S; Thompson, A; Macaskill, EJ; Viehstädt, N (2021-09-01)

• The DNA methylome of cervical cells can predict the presence of ovarian cancer 

  Barrett, JE; Jones, A; Evans, I; Reisel, D; Herzog, C; Chindera, K; Kristiansen, M; Leavy, OC; Manchanda, R; Bjorge, L (2022-02-01)

• COVID-19 and the impact on gynecologic cancer care 

  Manchanda, R; Oxley, S; Ghaem-Maghami, S; Sundar, S

• Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma 

  Bharwani, N; Miquel, ME; Powles, T; Dilks, P; Shawyer, A; Sahdev, A; Wilson, PD; Chowdhury, S; Berney, DM; Rockall, AG (2014-02-04)

• UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer 

  Barnes, A; Alonzi, R; Blackledge, M; Charles-Edwards, G; Collins, DJ; Cook, G; Coutts, G; Goh, V; Graves, M; Kelly, C (British Institute of Radiology, 2018)

• Vocal Tract Images Reveal Neural Representations of Sensorimotor Transformation During Speech Imitation 

  Carey, D; Miquel, ME; Evans, BG; Adank, P; McGettigan, C (2017-05)

• Surgical decision making in premenopausal BRCA carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a Qualitative Study 

  Manchanda, R; Gaba, F

  Background: Acceptance of the role of the fallopian tube in “ovarian” carcinogenesis and the detrimental sequelae of surgical menopause in pre-menopausal women following risk-reducing-salpingo-oophorectomy (RRSO), has ...

• Dynamic changes in full blood count (FBC) occurring in patients treated with immune checkpoint inhibitors (ICIs) to predict responses in patients with metastatic renal cell carcinoma (mRCC). 

  Abu Ghanem, Y; Choy, J; Jackson-Spence, F; Jovaisaite, A; Grant, M; Bex, A; Powles, T; Szabados, B (2020-05-20)

  Abstract e17110

• Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer. 

  Powles, T; Huddart, RA; Elliott, T; Sarker, S-J; Ackerman, C; Jones, R; Hussain, S; Crabb, S; Jagdev, S; Chester, J (2017-01)

  Purpose To establish whether maintenance lapatinib after first-line chemotherapy is beneficial in human epidermal growth factor receptor (HER) 1/HER2-positive metastatic urothelial bladder cancer (UBC). Methods Patients ...

• Early outcomes of robot-assisted radical prostatectomy following completion of a structured training curriculum: a single surgeon cohort study 

  Sehmbi, AS; Sridhar, AN; Sahadevan, K; Rai, BP; Nwangwu, P; Mohammed, A; Freeman, A; Mottrie, A; Olsson, MJ; Wiklund, NP (2020-01-01)

  © British Association of Urological Surgeons 2020. Objective: Technical skills in robot-assisted radical prostatectomy (RARP) are not mandated by the Intercollegiate Surgical Curriculum Programme. The European Association ...

• Reply to Pontus Eriksson, Gottfrid Sjodahl, and Fredrik Liedberg's Letter to the Editor re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder Cancer is Also Needed Protein Expression to Predict Outcome to Targeted Therapy in Bladder Cancer: Too Little, Too Late? 

  Powles, T; de Liano, AG; Ackerman, C (2017-11)

• How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project) 

  Brito-Zeron, P; Acar-Denizli, N; Ng, WF; Zeher, M; Rasmussen, A; Mandl, T; Seror, R; Li, X; Baldini, C; Gottenberg, J-E (2018)

• Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer 

  De Laere, B; Crippa, A; Ghysel, C; Ost, P; Rajan, P; Eklund, M; Dirix, L; Gronberg, H; Lindberg, J (2019-10)

• Identification of altered biological processes in heterogeneous RNA-sequencing data by discretization of expression profiles 

  Lauria, A; Peirone, S; Del Giudice, M; Priante, F; Rajan, P; Caselle, M; Oliviero, S; Cereda, M (2020-02-28)

View more